PNPLA3 and metabolic dysfunction-associated steatohepatitis: Currently, some serum biomarkers have been widely accepted for the diagnosis of NASH such as the circulating serum levels of CK-18, the single nucleotide polymorphisms located in PNPLA3 as well as the non-coding RNAs, etc. (90).